Trx2?

[Fixed by 35]

You need to remember that this is a small company that is dependent on sponsorship from organisations that fund research. TRX2 has been unwilling to work with a big pharmaceutical company, according to Whitfield, because they want to retain independence and don't want their research undermined or marginalised. As such, there is very little funding outside of the lab for things like customer care. This will continue, as research is still ongoing at the company.

Also, the company has to remain tight lipped because patent protection for a number of pharmaceutical products doesn't really exist in the UK.

As a result of TRX2's position, I would be surprised if big pharmaceutical companies didn't try to undermine them in their marketing literature and through forum plants.